Asthma and Chronic Obstructive Pulmonary Disease (Copd) in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis Publisher Pubmed



Ghoshouni H¹ ; Rafiei N² ; Yazdan Panah M³ ; Dehghani Firouzabadi D⁴ ; Mahmoudi F⁵ ; Asghariahmadabad M⁶ ; Shaygannejad V^{1, 7} ; Mirmosayyeb O¹
Source: Multiple Sclerosis and Related Disorders Published:2024

Abstract

Background: Studies have found that multiple sclerosis (MS) has an impact on the initiation or the course of asthma and chronic obstructive pulmonary disease (COPD). This review amied to investigate the prevalence and odds of asthma and COPD among people with MS (pwMS). Method: PubMed, Embase, Scopus, and Web of Science were systemically searched from inception to May 2023. R version 4.3.2 and random-effect model were used to calculate the pooled prevalence and odds ratio (OR), with their 95 % confidence interval (CI), in pwMS. Results: A total of 40 studies consisting of 287,702 pwMS were included. 37 studies indicated that the pooled prevalences of asthma and COPD among pwMS were 5.97 % (95 % CI: 4.62 %-7.69 %, I2=99 %) and 3.03 % (95 % CI: 1.82 %-5.00 %, I2=99 %), respectively. 24 studies on 236,469 pwMS and 85,328,673 healthy controls revealed that the overall odds of asthma and COPD in MS were 1.14 (95 % CI: 0.76–1.71, p-value=0.53, I2=97 %) and 1.28 (95 % CI: 1.11–1.47, p-value<0.01, I2=70 %), respectively. Conclusion: MS can increased the risk of developing COPD, while asthma does not exhibit a significant relationship with MS. Our study highlights the importance of identifying pwMS who face greater risks of respiratory issues to monitor efficiently and initiate suitable preventative actions. © 2024 Elsevier B.V.